Stemcell technologies INC:1109892 [26-000061]
Active Purchase Order Awarded Last action
- Contract number
- 75N90026P00026
- Awardee
-
Stemcell Technologies Inc. UEI ELPMWCGFK518
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,430
Award facts
- Contract value 100% obligated
- $19,430.40 Current and potential, with all options
- Completion date 83% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Kent, WA 98032, USA
Award details come from SAM.gov/FPDS.
About this award
Stemcell Technologies Inc. has been awarded a firm fixed-price purchase order valued at $19,430.40 by the NIH Clinical Center, with an ultimate completion date of December 19, 2026. The contract, which carries no small business set-aside designation, will be performed in Kent, Washington. As a subsidiary of the Canadian biotechnology company Stemcell Technologies, the awardee specializes in providing advanced biological research products and laboratory supplies essential to federal research institutions, particularly within the Department of Health and Human Services. The company's product portfolio includes cell isolation kits, cell culture media, cell separation systems, and research-grade reagents that support critical biomedical research across multiple scientific disciplines.
This purchase order likely represents a task order or delivery against Stemcell Technologies Inc.'s existing $10 million blanket purchase agreement with the NIH Office of Logistics and Acquisition Operations, which runs through December 31, 2025. The BPA serves as an indefinite delivery vehicle enabling streamlined procurement of specialized biological materials and scientific equipment across multiple NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Institute on Aging. Through this arrangement, the company continues to provide critical supplies that support ongoing research in infectious diseases, immunology, stem cell research, and translational medicine across the federal research enterprise.
Quick answers
Who was awarded contract 75N90026P00026?
75N90026P00026 was awarded to Stemcell Technologies Inc. by NIH Clinical Center (National Institutes of Health) on December 20, 2025.
How much is contract 75N90026P00026 worth?
The government has obligated $19,430 on 75N90026P00026.
Was contract 75N90026P00026 competed?
The extent of competition for 75N90026P00026 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award